<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01393041</url>
  </required_header>
  <id_info>
    <org_study_id>0901</org_study_id>
    <nct_id>NCT01393041</nct_id>
  </id_info>
  <brief_title>St. Jude Medical Angio-Seal VIP Vascular Closure Device</brief_title>
  <official_title>Clinical Study of the St. Jude Medical Angio-Seal VIP Vascular Closure Device Following Diagnostic and/or Interventional Endovascular Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical study is to assess device deployment characteristics and
      performance, as well as adverse events (vascular complications) of the SJM Angio-Seal VIP 6
      French device utilizing the SJM collagen.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Device deployment characteristics and performance</measure>
    <time_frame>At procedure</time_frame>
    <description>Device Deployment Success and rationale for non-deployment, procedural circumstances present during deployment such as type of procedure and procedure duration, Time to hemostasis, and assessment of vascular complications prior to leaving the cath lab. Data will be summarized using descriptive statistics in addition to listings or summary data tables being provided.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events (vascular complications)</measure>
    <time_frame>Ongoing</time_frame>
    <description>Adverse events (vascular complications) out to 30 days post-procedure on patients who have undegone a diagnostic and/or interventional procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to hemostasis</measure>
    <time_frame>The time elapsed from device deployment (cutting of the suture) to complete cessation of arterial bleeding, stratified as hemostasis in less than 1 minute, 1-5 minutes, or greater than 5 minutes.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of minor vascular complications</measure>
    <time_frame>Ongoing</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure</condition>
  <arm_group>
    <arm_group_label>Angio-Seal VIP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Angio-Seal VIP</intervention_name>
    <description>Vascular Closure Device</description>
    <arm_group_label>Angio-Seal VIP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is undergoing a diagnostic and/or interventional endovascular procedure via a
             retrograde femoral arterial access.

          2. Patient is of legal age.

          3. Patient has given written informed consent for participation prior to the procedure.

          4. Patient is willing to undergo all study procedures and adhere to data collection and
             follow-up requirements.

        Exclusion Criteria:

          1. Patient is unable to provide written informed consent.

          2. Patient has an inability or is unwilling to adhere to data collection and follow-up
             requirements.

          3. Patients who are pregnant or lactating.

          4. Patient may not participate in another clinical trial which has the potential to
             impact hemostasis (pharmaceutical/ device/ homeopathic).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Klinikum Luedenscheid</name>
      <address>
        <city>Luedenscheid</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2011</study_first_submitted>
  <study_first_submitted_qc>July 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2011</study_first_posted>
  <last_update_submitted>August 10, 2012</last_update_submitted>
  <last_update_submitted_qc>August 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

